secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2021-09-09T23:59:59+00:00
Accession:  0001062822-21-000055
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon appoints Jeffrey L. Wade as President, effective Oct 1, 2021; salary increased to $505k
--------------------------------------------------------------------------------

- Jeffrey L. Wade, current EVP/CFO, promoted to President effective Oct 1, 2021; reports to CEO Lonnel Coats.
- Base salary raised from $475,134 to $505,000; bonus target increased from 40% to 50% of base.
- Wade has been with Lexicon since 1999, previously a partner at Andrews & Kurth L.L.P.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000106282221000055/0001062822-21-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000106282221000055/lxrx-20210903.htm
  HTML page:      https://secwatch.observer/filing/0001062822-21-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer